RESULTS: Four weeks after subcutaneous autograft of LSCs in combination with Sertoli and myoid cells in castrate mice, the cells in graft expressed 3B-HSD, SOX-9 and A-SMA. Serum testosterone in castrated mice that received autograft was significantly higher compared to mice that did not receive autograft (22.4þ/-1.9 VS 11.9þ/-0.8 Ng/DL, p<0.05). Importantly, mice that received LSC autograft maintained production of LH and FSH with levels higher than mice that received testosterone pellet implant (LH 3.09þ/-1.47 VS 0.01þ/-0.01 ng/ml) (FSH 102.6þ/-28.1 VS 51.7þ/-7.4ng/ml) respectively. Furthermore, T levels consistently increased at 15, 30 and 60 days following subcutaneous autograft (12.01þ/-0.87ng/DL (neg CTL) vs 15.1þ/-1.50ng/DL (15 days Autograft) vs 22.26þ/-1.33ng/DL (30 days Autograft) vs 37.3þ/-9.6ng/DL (60 days Autograft)), demonstrating differentiating LSC within the autograft. In addition, we found that levels of 3BHSD were induced upon SAG (DHH inducer) treatment in-vitro conditions. Immunostaining autografts (4 weeks), containing LSCs treated with SAG before subcutaneous implantation, showed higher levels of SOX9, and A-SMA. Importantly, T levels were significantly higher (p<0.05) in mice received SAG treated autografts vs negative controls (23.95þ/-4.11 Ng/DL vs 11.91þ/-0.80 Ng/DL). Collectively these results establish that Hedgehog signalling induces survival of adjacent testicular cells and regulates graft function.
INTRODUCTION AND OBJECTIVES: Beta-adrenoceptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. Mirabegron is a selective beta3-adrenoceptor (ADRB3) agonist that has been approved for the treatment of overactive bladder. Studies in rats showed that mirabegron was associated with atrophy and/or reduced weights of the accessory reproductive organs, and in females, prolonged diestrus and decreased numbers of live fetuses. In this study, we evaluated the potential effects of mirabegron on the molecular expressions in rat Sertoli cell (SC) primary culture.
METHODS: SCs were purified from testes of 18-day-old Sprague-Dawley rats. Primary cultures were treated with 1mM mirabegron in the absence or presence of 10mM U0126, a selective noncompetitive inhibitor of Mitogen-Activated Protein (MAP) kinase kinase. Immunofluorescent (IF) study was performed using the primary SC culture to determine the expression of ADRB3 in rat SCs. Protein samples were extracted from whole cell homogenates. Western blot (WB) analysis was performed to explore phosphorylation of MAP kinases. Total RNA was also extracted from SCs. Quantitative real-time RT-PCR (q-PCR) analysis was conducted to determine the expression levels of tight junction related mRNAs.
RESULTS: IF study showed that ADRB3 was present in rat SCs. WB analyses showed that mirabegron treatment induced the significant activation of p44/42 MAPK. Q-PCR showed that mirabegron treatment led to significant increase in claudin-11 mRNA levels. After additional treatment with U0126, mirabegron-induced up-regulation of Claudin-11 had reduced.
CONCLUSIONS: These data suggest that ADRB3 is present in rat SCs. ADRB3 may be associated with spermatogenesis through p44/ 42 MAPK induced tight junction molecules alteration in rat SCs.
Source of Funding: none

MP60-03 SERUM METABOLOMIC ANALYSIS IDENTIFIES UNIQUE SIGNATURES IN AZOOSPERMIC MEN
Zhe Zhang*, Hui Jiang, Beijing, China, People's Republic of INTRODUCTION AND OBJECTIVES: Infertility is considered as a major health problem, and azoospermia cases due to 10% of male factors. Azoospemia is the most challenging task for andrologist, for these patients rarely can father their own genetic offspring. Therefore, it is imperative to investigate the molecular mechanism underlying idiopathic azoospermia and seek a potential treatment.
METHODS: The subjects with idiopathic azoospermia were enrolled from Reproductive Center of Peking University Third Hospital (PUTH), and healthy controls form Human Sperm Bank of PUTH. The blood samples from both idiopathic azoospermia and healthy control were used for untargeted metabolites screening by high performance liquid chromatography. All metabolites were introduced to MetaboAnalyst3.0 for data processing, PCA and OPLS-DA was performed to reduce the dimensionality of the data and to reveal any clustering in an unsupervised manner. The significance of variable was quantified by the variable importance in the project (VIP) plot of the established OPLS-DA model. Mann-Whitney U test and chi-square test. Metabolites relative content were analyzed with two-tailed Student's t-test using. Any difference with p < 0.05 was considered statistically significant.
RESULTS: A total of 22 idiopathic azoospermic patients and 31 normal controls were enrolled in the case-control sutdy. In the group of azoospermia, infertile men were identified as early/late maturation arrest, Sertoli-cell only. There is an obvious segregation of metabolomic profiles was observed in the group of azoospermic cases in PCA model. The entired data set was identified by a further supervised analysis of PLS-DA, and revealed a clearer separation of azoospermia from the fertile cases. Extracted variables that contributed the most in the case control group differentiation were chosen to be biomarkers for idiopathic azoospermic diagnosis, and acetylcarnitine, citrate, arginine and taurine were identified. The pathways had the top 5 pathway impact are: A. Alanine, aspartate and glutamate metabolism; B. Citrate cycle (TCA cycle); C. Arginine and proline metabolism; D. Butanoate metabolism; E. D-Glutamine and D-glutamate metabolism.
CONCLUSIONS: Several potential metabolites were identified that are closely associated to energy production and oxidative stress in spermatogenesis. Biosynthesis and metabolism of these metabolites may contribute to the aetiologies of idiopathic azoospermia. Our findings suggested that metabolomics fingerprinting could provide a promising screening approach to detect possible biomarkers and improve our understanding of mechasnisms underlying male infertility, and eventually aiding to etiological diagnose and therapy intervention. been proposed as potential biomarkers of obstructive azoospermia. Our goal was to evaluate sperm specific proteins and microscopic sperm presence in vasal fluid at time of vasectomy reversal. METHODS: Patients undergoing vasectomy reversal were enrolled between 2015-2016. Samples were grouped into groups based on microscopic presence of sperm. Proteomic profiles were generated using liquid chromatography/ tandem mass spectrometry, and MS/MS protein spectral counts compared between individuals and treatment groups controlling for less than 5% false discovery rates (FDRs). Differential Expression was assessed using Bioconductor's edgeR package. Proteins were then matched with the human swissprot database. Samples were analyzed with regards to content of 8 known sperm specific proteins.
RESULTS: We analyzed 53 vasal samples from 27 patients. A total of 1,692 unique proteins were detected. The presence of sperm specific proteins varied regardless of the microscopic presence of sperm (Table 1) . Cysteine-rich secretory protein was abundant in all samples, while Transketolase-like protein 1 and Sperm-associated antigen 11B were absent or very low counts in all samples. Thus, using the 5 remaining sperm specific proteins we were able to identify 273 unique proteins as potential sperm biomarkers; however, no potential biomarkers correlated with microscopic sperm findings. Most common GO terms included viral process, signal transduction, and innate immune response, as well as protein folding and spermatogenesis.
CONCLUSIONS: Cysteine-rich secretory protein was abundant in samples regardless of microscopic sperm presence, rendering this a potential biomarker. We identified many processes contributing to the variability of the proteomic profile of vasal fluid at time of vasectomy reversal to include spermatogenesis, degradation, immune and inflammatory responses. Further evaluation is needed to determine if a potential protein biomarker exists that could predict vasectomy reversal fertility outcomes that could alleviate the need for intra-operative light microscopy, aid in procedural planning and provide a counseling tool for patients.
Source of Funding: none
MP60-05 MELATONIN HORMONE LEVEL IN SERUM AND SEMINAL PLASMA OF PATIENTS WITH IDIOPATHIC OLIGOASTHENOTERATOZOOSPERMIA
Hassan Ibrahim*, Qena, Egypt; Moustafa El Taieb, Aswan, Egypt; Hanan Fayed, Nahed Fares, Qena, Egypt INTRODUCTION AND OBJECTIVES: Melatonin is a sleep inducing hormone and a hormone of darkness, secreted by the pineal gland. It has a role in idiopathic oligoasthenoteratozoospermia (iOAT) male infertility by its potent antioxidant effect. We aim to estimate seminal plasma and serum melatonin levels in iOAT patients compared with normal fertile male patients and the effect of exposure to light at night on their semen parameters.
METHODS: A clinical cross-sectional case control study, in which semen and serum samples were collected from 50 infertile men ( 34 men exposed to light at night an 16 men not exposed) and 50 fertile ones. WHO, 2010 semen analysis was done. Serum and seminal plasma were assessed for melatonin level using enzyme-linked immunosorbent assay (ELISA).
RESULTS: There was significant decrease in seminal plasma and serum melatonin levels in iOAT patients (P¼0.0004,P¼0.01) respectively in comparative to control group (Table a) . Statistically significant decrease was found in the serum and seminal plasma levels of melatonin hormone in exposed cases to light at night (night shift work) than non-exposed cases (P< 0.0001), (P¼ 0.02) respectively (Table b) . There was also a negative significant correlation between semen parameters of iOAT patients (concentration, motility and abnormal forms) and exposure to light at night (p<0.0001), (p¼0.04) and (p¼0.04) respectively.
CONCLUSIONS: Darkening and sleep at night may improve semen parameters in iOAT patients via the antioxidant activity of melatonin hormone in the serum and seminal plasma as demonstrated by the negative effect of exposure to light at night on serum and seminal plasma level of melatonin and consequently on the semen parameters.
Source of Funding: none
MP60-06
UNCOVERING BIOLOGY OF KLINFELTER SYNDROME (47,XXY) INFERTILITY USING NOVEL 10X GENOMICS SINGLE CELL SEQUENCING INTRODUCTION AND OBJECTIVES: Finding sperm in rare areas of dilated seminiferous tubules (DSFTs) among the mass of collapsed seminiferous tubules (CSFTs) in men with Klinefelter syndrome (KS) is difficult to explain. Two plausible explanations of sperm production in KS are either spontaneous rescue of 47,XXY and loss of the additional X ch. in some areas of testis, or existence of low grade mosaicism in tissue levels. Our lab has confirmed that all pre-meiotic cells in testis have two X ch. including spermatogonial stem cells (SSCs). Thus, we believe that along SFTs in men with KS there are similar number of SSCs, but due to optimal niche in some regions of testis the rescue of genetic defect is possible. The aim of this study was to characterize heterogeneity of SSCs and somatic cells along the DSFTs and CSFTs from same patient and same testis using single cell sequencing.
